| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.487 | 1.182 | 2.247 | 1.834 | 2.962 | 2.725 | 3.285 | 4.934 | 11.666 | 14.642 |
| Total Income - EUR | 1.554 | 1.182 | 2.247 | 1.834 | 2.962 | 2.725 | 3.285 | 4.934 | 11.666 | 14.642 |
| Total Expenses - EUR | 1.473 | 1.156 | 1.025 | 1.791 | 938 | 639 | 693 | 923 | 1.557 | 952 |
| Gross Profit/Loss - EUR | 81 | 26 | 1.222 | 43 | 2.024 | 2.087 | 2.593 | 4.010 | 10.108 | 13.690 |
| Net Profit/Loss - EUR | 34 | -10 | 1.154 | -12 | 1.936 | 2.013 | 2.494 | 3.883 | 8.734 | 11.500 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Livstan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.912 | 9.811 | 9.645 | 9.468 | 9.285 | 9.109 | 9.424 | 9.223 | 8.965 | 8.858 |
| Current Assets | 908 | 1.568 | 3.492 | 4.032 | 4.690 | 6.656 | 4.116 | 7.642 | 17.058 | 7.944 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 260 | 266 | 0 | 3.633 | 0 |
| Cash | 908 | 1.567 | 3.492 | 4.032 | 4.690 | 6.396 | 3.850 | 7.642 | 13.425 | 7.944 |
| Shareholders Funds | 5.917 | 5.847 | 6.902 | 6.763 | 8.567 | 10.418 | 12.681 | 16.614 | 25.298 | 15.133 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.196 | 7.802 | 8.467 | 8.928 | 5.408 | 5.347 | 859 | 250 | 725 | 1.668 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Livstan Med Srl